(Date:11/24/2009)... SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neu...nyfocusedondevelopingandcommercializingnovelpainma...,PresidentandChiefExecutiveOfficer,isscheduledtopr...ce,tobeheldDecember1-2,2009atTheNewYorkPalaceHotel...ieri,ChiefFinancialOfficer,willbeavailabletorespon...
(Date:11/24/2009)...,Primaryefficacyendpointhasbeenmetforpatientswitha... QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZe...lobalbiopharmaceuticalcompanyfocusedonendocrinethe...fromaPhase2studywithitstargetedcytotoxicpeptidecon...ncedorrecurrentendometrialcancer.Inapersonalizedhe...
(Date:11/24/2009)... REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall/--...tRandyScott,GenomicHealth,sExecutiveChairman,willp...nceinNewYorkCityonTuesday,December1,2009at10:00a.m...ebcastofthepresentation,visittheInvestorRelationss...enomichealth.com .Pleaseconnecttothewebsiteatleast...
(Date:11/24/2009)... SEATTLE,Nov.24/PRNewswire-FirstCall/--CellTherape...esentatthe21stAnnualPiperJaffrayHealthCareConferen...wYorkPalaceHotel. ,, CTIwillpresentonTuesday,De...liveaudiowebcastofCTI,spresentationwillbeavailable...bleforreplayafterwards. , ,PiperJaffrayHealthCare...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2...nal Webinar "How Organizations Can Make the Transi...ware and featuring Virtify, Inc. , , CAMBRIDGE, ... ), the market leader in Enterprise Content Compli...ware ( www.pilgrimsoftware.com ), a provider of ...) software solutions, will host a complimentary W...
...il 30 /PRNewswire-Asia-FirstCall/ -- China-Biotics...pany"), a leading Chinese firm,specializing in the...,distribution of probiotics products ( http://chn-...pany,s management will present at the upcoming,Chi...ons in New York on May 18,2009. , The date, ti...
... Amicus Therapeutics (Nasdaq: FOLD ) will annou... regular close of markets on Thursday, May 7, 2009...ive conference call and webcast that afternoon at ...stors may access the conference call at 5 p.m. EDT...4830 (international). A telephonic replay of the c...
Other Biology Technology:Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes' 2Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes' 3China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 2China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 3Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date 2...r preparation of minimal and synthetic defined yea...ot contain amino acids. Both bulk and convenient s...ins reagents to prepare 500 ml of 10X YNB for Pich...edia. Store at 15C to 30C. Guaranteed stable for 6...
...its are ideal for studying or screening novel prog...ence polarization (FP) The homogenous assay utiliz...nd binding domain of human progesterone receptor [...ed progesterone ligand, Fluormone PL Green or PL R...
...Fc regions of many mammalian immunoglobulins. Prot...s affinity adsorbents to purify immunoglobulins (a... hybridoma ascites fluids, tissue culture supernat...re also commonly used to capture immune complexes ...
...eered to match the speed of biochemical reactions ...wide. It uses 1.5 mm Roche LightCycler Capillary t...rature cycling due to their thin walls and extreme...ng glass capillary tubes and air as the cycling me...
Biology Products: